EUVIMEDEUVIMED entdecken
Open Access

Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis

Xiaoyan Li, Jinping Wang, Zongliang Guo, Yong Ma, Dawei Xu, Daguang Fan, Peng Dai, Yifan Chen, Qiongwen Liu, Jinke Jiao, Jinhan Fan, Ningxue Wu und 2 weitere

Aging · 2023

DOI: 10.18632/aging.205334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Xiaoyan Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, Shanxi Provincial People’s Hospital, Affiliate of Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Copper, Liver Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Dysregulated copper metabolism has been noticed in many types of cancer including hepatocellular carcinoma (HCC); however, a comprehensive understanding about this dysregulation still remains unclear in HCC. METHODS: A set of bioinformatic tools was integrated to analyze the expression and prognostic significance of copper metabolism-related genes. A related risk score, termed as CMscore, was developed via univariate Cox regression, least absolute shrinkage and selection operator (LASSO) Cox regression and multivariate Cox regression. Pathway enrichment analyses and tumor immune cell infiltration were further investigated in CMscore stratified HCC patients. Weighted correlation network analysis (WGCNA) was used to identify potential regulator of cuproptosis. RESULTS: Copper metabolism was dysregulated in HCC. HCC patients in the high-CMscore group showed a significantly lower overall survival (OS) and enriched in most cancer-related pathways. Besides, HCC patients with high CMscore had higher expression of pro-tumor immune infiltrates and immune checkpoints. Moreover, cancer patients with high CMscore from two large cohorts exhibited significantly prolonged survival time after immunotherapy. WGCNA and subsequently correlation analysis revealed that SLC27A5 might be a potential regulator of cuproptosis in HCC. In vitro experiments revealed that SLC27A5 inhibited cell proliferation and migration of HCC cells and could upregulate FDX1, the key regulator of cuproptosis. SIGNIFICANCE: The CMscore is helpful in clustering HCC patients with distinct prognosis, gene mutation signatures, and sensitivity to immunotherapy. SLC27A5 might serve as a potential target in the induction of cuproptosis in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularCopperLiver NeoplasmsHumansApoptosisCell LineCell ProliferationFatty Acid Transport ProteinsPrognosisTumor Microenvironment

Stichwörter der Autor:innen

SLC27A5copper metabolismcuproptosishepatocellular carcinomaimmunotherapy

Substanzen

CopperFatty Acid Transport ProteinsSLC27A5 protein, human

Autor:innen und Institutionen

  • Department of Blood Transfusion, Shanxi Provincial People’s Hospital, Affiliate of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Central Laboratory, Shanxi Provincial People's Hospital, Affiliate of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Ultrasound, Shanxi Provincial People's Hospital, Affiliate of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of General Surgery, Shanxi Province Cancer Hospital, Affiliated of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Thoracic Surgery, Shanxi Province Cancer Hospital, Affiliated of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Shanxi Provincial People's Hospital, Affiliate of Shanxi Medical University, Taiyuan, Shanxi, China.

Zitieren

APA

Li, X., Wang, J., Guo, Z., Ma, Y., Xu, D., Fan, D., Dai, P., Chen, Y., Liu, Q., Jiao, J., Fan, J., Wu, N., Li, X., & Li, G. (2023). Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis. Aging. https://doi.org/10.18632/aging.205334

Vancouver

Li X, Wang J, Guo Z, Ma Y, Xu D, Fan D, et al. Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis. Aging. 2023. doi:10.18632/aging.205334

BibTeX
@article{Li2023,
  author = {Li, Xiaoyan and Wang, Jinping and Guo, Zongliang and Ma, Yong and Xu, Dawei and Fan, Daguang and Dai, Peng and Chen, Yifan and Liu, Qiongwen and Jiao, Jinke and Fan, Jinhan and Wu, Ningxue and Li, Xin and Li, Guoyin},
  title = {Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.205334}
}
Kostenlos starten →